1
2020 FY Series
+ COVID-19 Implications
PHARMACEUTICAL COUNTRY REPORT Ukraine Pharmaceutical Country Report 2020 FY
UKRAINE PHARMACEUTICAL COUNTRY REPORT 2020 FY
NAVIGATION
2
Summary & Benefits
a.
Historical Context
b.
Further Development
c.
Economic Situation
d.
Macroeconomic Indicators PHARMA MARKET
a.
Stakeholders
b.
Supply Chain
c.
Segments
d.
Retail Channel
e.
Production & Foreign Trade
f.
Hospital Channel
g.
Market Forecast
h.
Top-15 companies
i.
Top-10 brands
j.
Regulatory Environment
3.
12 slides
2.
4 slides
COUNTRY SUMMARY
MARKET ACCESS
a.
Regulatory Environment
b.
Regulatory Changes
c.
Key Stakeholders
d.
Marketing Authorization
e.
Pricing Regulation
f.
National Formulary
g.
Essential Medicines List
h.
Reimbursement
I
Public Procurement
j.
HTA Ecosystem
15 slides
1.
The Report uncovers the 2020 FY business trends of the pharmaceutical market of Ukraine. It provides a forecast of total pharmaceutical market sales for the next three years (2021-2023), considering all the COVID-19-concerned crisis implications.
Real pages screenshots
The publication also provides the most recent insight into the country's socio-political development, including the anticipations regarding the country's economic prospects in 2020-2022. The Report also overviews Ukraine's healthcare system, portrays its epidemiology (including COVID-19 statistics) and demographics. It also depicts pharmaceutical market access regulation features in Ukraine, including a step-by-step process of ALL possible processes companies should undergo to start selling their products in Ukraine. TECHNICAL DETAILS  Reporting period: 2013-2020e FY historical data  Forecast period: 2021-2023  Pharma market covered: market segments, Rx/OTC, Local/Foreign, Pricing, Pharmacy infrastructure,  Market Access covered: Road-to-market pathway, core processes, regulation, inclusion requirements, pricing and reimbursement, national formulary etc.  Publication date: December 2020  Language: ENG  Supplementary files: .xlsx, .pptx, .pdf  All the data in the Report is given in the presentation-ready format—copy-paste ready for your corporate presentation.
WHO WILL BENEFIT FROM THE REPORT? Âť Local & Regional Management Âť Product & Marketing Management Âť Business Development Âť Investment Institutions
Âť Âť Âť Âť
Market Access Management Launch Planning Decision-Making Executives Private Equity Funds
WHY IT IS IMPORTANT FOR DECISION MAKERS IN PHARMA: HEALTHCARE
a.
Spending
b.
Infrastructure & Workforce
c.
Epidemiology
d.
COVID-19 Implications
â?” Abbreviations & Definitions đ&#x;—¨ List of Tables & Figures
6 slides
4.
 You will get a helicopter-view snapshot of the Life Sciences sector of Ukraine: its healthcare system and pharmaceutical market, epidemiology and demography trends;  It will help you understand current Ukraine’s pharmaceutical market trends;  It clearly shows the structure of the local pharmaceutical market by segments: retail, hospital, reimbursement;  You will be able to adjust your planned data to a possible growth curve of a local pharmaceutical market for a horizon of 2021-2023;  The Report will show you the biggest pharmaceutical companies and brands on the Ukrainian market;  You will understand how authorities regulate the market access landscape and see all process schemes for a pharmaceutical product or medical device.
Ukraine Pharmaceutical Country Report 2020 FY
December 2020
UKRAINE PHARMACEUTICAL COUNTRY REPORT 2020 FY
NAVIGATION
3
Report Details
a.
Historical Context
b.
Further Development
c.
Economic Situation
d.
Macroeconomic Indicators
2.
Real pages screenshots
COUNTRY SUMMARY
4 slides
1.
49 Slides:
Âť 41 Figures, Schemes & Diagrams
PHARMA MARKET
Âť 16 Tables
Stakeholders
b.
Supply Chain
c.
Segments
d.
Retail Channel
e.
Production & Foreign Trade
f.
Hospital Channel
g.
Market Forecast
h.
Top-15 companies
i.
Top-10 brands
Âť Professional business report in the .pdf format
j.
Regulatory Environment
Âť Data repository in the .xlsx format
MARKET ACCESS Regulatory Environment
b.
Regulatory Changes
c.
Key Stakeholders
d.
Marketing Authorization
e.
Pricing Regulation
f.
National Formulary
g.
Essential Medicines List
h.
Reimbursement
I
Public Procurement
j.
HTA Ecosystem
4.
Spending
b.
Infrastructure & Workforce
c.
Epidemiology
d.
COVID-19 Implications
Âť Fully-editable .pptx file
Âť All graphic objects are 100% editable and customizable Âť All objects are additionally provided in the supplementary source .xlsx file. Âť Free to copy-paste all objects into your corporate-style brochure, report or publication.
HEALTHCARE
a.
3 files:
Free to customize: 15 slides
a.
6 slides
3.
12 slides
a.
Support 24/7: Âť We support our customers in any questions related to the methodology, technical, and sources questions.
â?” Abbreviations & Definitions đ&#x;—¨ List of Tables & Figures
Ukraine Pharmaceutical Country Report 2020 FY
December 2020
UKRAINE PHARMACEUTICAL COUNTRY REPORT 2020 FY
NAVIGATION
4
Slide Elements Example
Historical Context
b.
Further Development
c.
Economic Situation
d.
Macroeconomic Indicators
Supplementary summary, notes, conclusions
b.
Supply Chain
c.
Segments
d.
Retail Channel
e.
Production & Foreign Trade
f.
Hospital Channel
g.
Market Forecast
h.
Top-15 companies
i.
Top-10 brands
j.
Regulatory Environment
12 slides
Stakeholders
Regulatory Environment
b.
Regulatory Changes
c.
Key Stakeholders
d.
Marketing Authorization
e.
Pricing Regulation
f.
National Formulary
g.
Essential Medicines List
h.
Reimbursement
I
Public Procurement
j.
HTA Ecosystem
15 slides
MARKET ACCESS
a.
4.
Figures, Graphics, Schemes etc.
PHARMA MARKET
a.
3.
Slide Name
4 slides
a.
2.
Contents/ Navigation
COUNTRY SUMMARY
HEALTHCARE
a.
Spending
b.
Infrastructure & Workforce
c.
Epidemiology
d.
COVID-19 Implications
6 slides
1.
â?” Abbreviations & Definitions đ&#x;—¨ List of Tables & Figures
Editable elements Ukraine Pharmaceutical Country Report 2020 FY
Graphics details
Information sources December 2020
UKRAINE PHARMACEUTICAL COUNTRY REPORT 2020 FY
NAVIGATION
5
Slide Elements Example
Historical Context
b.
Further Development
c.
Economic Situation
d.
Macroeconomic Indicators
b.
Supply Chain
c.
Segments
d.
Retail Channel
e.
Production & Foreign Trade
f.
Hospital Channel
g.
Market Forecast
h.
Top-15 companies
i.
Top-10 brands
j.
Regulatory Environment
12 slides
Stakeholders
Regulatory Environment
b.
Regulatory Changes
c.
Key Stakeholders
d.
Marketing Authorization
e.
Pricing Regulation
f.
National Formulary
g.
Essential Medicines List
h.
Reimbursement
I
Public Procurement
j.
HTA Ecosystem
15 slides
MARKET ACCESS
a.
4.
Supplementary summary, notes, conclusions
PHARMA MARKET
a.
3.
Slide Name
4 slides
a.
2.
Contents/ Navigation
COUNTRY SUMMARY
HEALTHCARE
a.
Spending
b.
Infrastructure & Workforce
c.
Epidemiology
d.
COVID-19 Implications
6 slides
1.
â?” Abbreviations & Definitions đ&#x;—¨ List of Tables & Figures
Scheme Ukraine Pharmaceutical Country Report 2020 FY
Scheme details
Information sources December 2020
UKRAINE PHARMACEUTICAL COUNTRY REPORT 2020 FY
NAVIGATION
6
List of Elements Used in the Report
a.
Historical Context
b.
Further Development
c.
Economic Situation
d.
Macroeconomic Indicators
a.
Stakeholders
b.
Supply Chain
c.
Segments
d.
Retail Channel
e.
Production & Foreign Trade
f.
Hospital Channel
g.
Market Forecast
h.
Top-15 companies
i.
Top-10 brands
j.
Regulatory Environment
3.
MARKET ACCESS
a.
Regulatory Environment
b.
Regulatory Changes
c.
Key Stakeholders
d.
Marketing Authorization
e.
Pricing Regulation
f.
National Formulary
g.
Essential Medicines List
h.
Reimbursement
I
Public Procurement
j.
HTA Ecosystem
4.
12 slides
PHARMA MARKET
15 slides
2.
4 slides
COUNTRY SUMMARY
HEALTHCARE
a.
Spending
b.
Infrastructure & Workforce
c.
Epidemiology
d.
COVID-19 Implications
â?” Abbreviations & Definitions đ&#x;—¨ List of Tables & Figures
6 slides
1.
FIGURES 1 Real GDP and GDP growth rate of UKR (2013-2019; 2020-2023(f*)) 2 UAH Exchange Rate (2013-2023(f**)) 3 Pharmaceutical Market Supply Chain Scheme in Ukraine 4 Shares of Retail and Hospital Segments (All Categories), VALUES and VOLUMES (2013-2020e) 5 Total Market by Retail & Hospitals Channels. Sales Dynamics. VALUES (2013-2020e) 6 Total Market by Retail & Hospitals Channels. Sales Dynamics. VOLUMES (2013-2020e) 7 Weighted Average Cost of a Pack per Segment (USD, 2013-2023f) 8 Retail Sales Dynamics. All Categories. VALUES (1H 2013-1H/2020) Retail Sales Dynamics. All Categories. VOLUMES (1H 2013-1H/2020) 9 Number of Pharma PoS in Ukraine (2015-2020, bop) 10 Shares of Main Categories of the Pharmacy Assortment (1H/2020) 11 Shares of Rx & OTC Products in the Retail Segment. VALUES & VOLUMES (2013-1H/2020) 12 Retail Sales of Medical Devices, Food Supplements, Cosmetics. VALUES & VOLUMES (2013-2020e) 13 Shares of Foreign and Local MNFs. VALUES & VOLUMES (2013-2019; 1H/2020) 14 Total Value of Local Production of Pharmaceutical Products. VALUES (2013-2023f) 15 Total Value of Exported Pharmaceutical Products from Ukraine 16 Total Value of Imported Pharmaceutical Products into the Territory of Ukraine 17 Key Directions of the “Affordable Medicines� Program 18 Hospital Sales Dynamics. VALUES (2013-2020e) 19 Hospital Sales Dynamics. VOLUMES (2013-2020e) 20 Drugs Reimbursed under the “Affordable Medicines� Program. VALUES (2017-2020e) 21 Total Market Sales Forecast, VALUES (2020-2023) 22 Total Market Sales Forecast, VOLUMES (2020-2023) 23 National Marketing Authorization Procedure 24 Marketing Authorization Recognition Procedure 25 National Marketing Authorization Simplified Procedure for Medicines Regardless the Country of Origin 26 National Marketing Authorization Simplified Procedure for Medicines Originated from Listed Counties 27 Implemented Public Policies to Control Pharmaceutical Spending in Ukraine 28 A Scheme of Price Regulation for Products Listed in the EDL 29 National Formulary System in Ukraine Structure Scheme 30 National Formulary Inclusion Process in Ukraine Scheme 31 Essential Medicines List Inclusion Process in Ukraine Scheme 32 Affordable Medicines Program Operation Scheme 33 Public Purchases in Scheme 34 SEC HTA Department Structure 35 HTA System Development Plans 36 HTA Stakeholders in Ukraine 37 Role of HTA in Public Decision-Making in Ukraine 38 Annual Healthcare Budget of Ukraine in % to GDP (2013-2021p) 39 Spending on Pharmaceutical Products by Channels, VALUES (7M 2020) 40 Number of newly emerged COVID-19 cases in Ukraine, weekly (Mar 03-Oct 11) 41
Ukraine Pharmaceutical Country Report 2020 FY
TABLES
1
Key country indicators
2
Main macroeconomic indicators (2013-2019, 2020(e)-2023(f))
3
Ukrainian Pharmaceutical Market by Segments, USD mln
4
Retail Segment Sales by Categories, USD mln
5
TOP-10 Recipients of Reimbursed Funds Under the “Affordable Medicines� Program
6
Top-15 Companies on the Market (Retail segment)
7
Top-10 Products on the Market in 1H 2018-1H/2020, by sales in values (Retail segment)
8
Total State Budget and Budget on the Healthcare in Ukraine (2013-2021p)
9
Healthcare Infrastructure of Ukraine by jurisdiction (2012-2019)
10
Number of Hospitals under the MOH by types (2019)
11
Number of physicians by main specializations in Ukraine (under the MOH), persons (20172019, eop)
12
Key Demographic Indicators, 2012-2019
13
Incidence rates of certain infectious diseases (2014-2019)
14
HIV-positive and AIDS patients in Ukraine (2000, 2005, 2010, 2015, 2017-2019)
15
Population Incidence of Malignant Neoplasms by Individual Localizations in 2019
16
Main Causes of Death in 2017-2019 December 2020
UKRAINE PHARMACEUTICAL COUNTRY REPORT 2020 FY
NAVIGATION
7
1 Report Pricing Options
a.
Historical Context
b.
Further Development
c.
Economic Situation
d.
Macroeconomic Indicators
a.
Stakeholders
b.
Supply Chain
c.
Segments
d.
Retail Channel
e.
Production & Foreign Trade
f.
Hospital Channel
g.
Market Forecast
h.
Top-15 companies
i.
Top-10 brands
j.
Regulatory Environment
3.
MARKET ACCESS
a.
Regulatory Environment
b.
Regulatory Changes
c.
Key Stakeholders
d.
Marketing Authorization
e.
Pricing Regulation
f.
National Formulary
g.
Essential Medicines List
h.
Reimbursement
I
Public Procurement
j.
HTA Ecosystem
4.
12 slides
PHARMA MARKET
15 slides
2.
4 slides
COUNTRY SUMMARY
HEALTHCARE
a.
Spending
b.
Infrastructure & Workforce
c.
Epidemiology
d.
COVID-19 Implications
â?” Abbreviations & Definitions đ&#x;—¨ List of Tables & Figures
6 slides
1.
Price, EUR
Pharma Market
Market Access
Full report
650,00
650,00
910,00 -
1. a. b. c. d.
COUNTRY SUMMARY Historical Context Further Development Economic Situation Macroeconomic Indicators
+ + + + +
+ + + + +
+ + + + +
2. a. b. c. d. e. f. g. h. i. j.
PHARMA MARKET Stakeholders Supply Chain Segments Retail Channel Production & Foreign Trade Hospital Channel Market Forecast Top-15 companies Top-10 brands Regulatory Environment
+ + + + + + + + + + +
-
+ + + + + + + + + + +
3. a. b. c. d. e. f. g. h. I j.
MARKET ACCESS Regulatory Environment Regulatory Changes Key Stakeholders Marketing Authorization Pricing Regulation National Formulary Essential Medicines List Reimbursement Public Procurement HTA Ecosystem
-
+ + + + + + + + + + +
+ + + + + + + + + + +
4. a. b. c. d.
HEALTHCARE Spending Infrastructure & Workforce Epidemiology COVID-19 Implications
+ + + + +
+ + + + +
+ + + + +
Three files:
Yes
Yes
Yes
24/7 support:
Yes
Yes
Yes
Ukraine Pharmaceutical Country Report 2020 FY
30% economy: The most valuable option
Report: Ukraine Pharmaceutical Country Report 1H/ 2020
Language: English Deliverable: Publication date: December 2020
You can purchase this Report using any from these two options: 1. PURCHASE BY INVOICE. We will send you an Invoice ASAP after you provide us your details by filling-in the following online form. Request Invoice
2. PURCHASE BY CREDIT/ DEBIT CARD. We will send you a Request for a Payment via our Payoneer account after you provide us your credentials by filling-in the following online form. Purchase by card
Read more about the Payoneer payments service at: https://www.payoneer.com/
December 2020
UKRAINE PHARMACEUTICAL COUNTRY REPORT 1H/2020
NAVIGATION
8
How to purchase the Report
a.
Historical Context
b.
Further Development
c.
Economic Situation
d.
Macroeconomic Indicators
b.
Supply Chain
c.
Segments
d.
Retail Channel
e.
Production & Foreign Trade
f.
Hospital Channel
g.
Market Forecast
h.
Top-15 companies
i.
Top-10 brands
j.
Regulatory Environment
Maria VARLAM
Partner, Life Sciences Market Access & Insights Eastern Europe, CIS, Central Asia
Life Sciences Market Access Specialist Eastern Europe, CIS, Central Asia
ebrovko@upharma-c.com +380 (98) 224-98-64
mvarlam@upharma-c.com +380 (66) 036-20-48
MARKET ACCESS
a.
Regulatory Environment
b.
Regulatory Changes
c.
Key Stakeholders
d.
Marketing Authorization
e.
Pricing Regulation
f.
National Formulary
g.
Essential Medicines List
h.
Reimbursement
I
Public Procurement
j.
HTA Ecosystem
4.
12 slides
Stakeholders
3.
Eugene BROVKO
PHARMA MARKET
a.
Contact us for more details:
15 slides
2.
4 slides
COUNTRY SUMMARY
COPYRIGHTS & AUTHORS All rights reserved. No part of this publication may be reproduced in any manner without the prior written permission of UPharma Consulting.
HEALTHCARE
a.
Spending
b.
Infrastructure & Workforce
c.
Epidemiology
d.
COVID-19 Implications
â?” Abbreviations & Definitions
6 slides
1.
UPharma Consulting LLC is registered in Ukraine, Kyiv, 03039, 30th Holosiivskiy Avenue, building B, office 58, upharma-c.com/en/ Additional information regarding this publication will be furnished upon request. UPharma Consulting is a professional consulting company, operating in the Life Sciences sector. We analyze pharmaceutical & MedTech markets and healthcare industries, plan launching new products, recruit pharmaceutical business professionals and support investment decisions across the CIS and Central Asian region
DISCLAIMER These publications have been prepared by the research department of UPharma Consulting (“UPC�). They are provided to our clients and industry stakeholders for information purposes only, and UPC makes no express or implied warranties and expressly disclaims all warranties of merchantability or fitness for a particular purpose or use concerning any data included in this publication.
UPC will not treat unauthorized recipients of this report as its clients.
đ&#x;—¨ List of Tables & Figures
Ukraine Pharmaceutical Country Report 2020 FY
December 2020
9
Series
Social media
+ COVID-19 Implications
Ukraine Pharmaceutical Country Report 2020 FY
FY 2020